The expression of immune checkpoint molecules like PD-L1 on EBV-infected B cells and PD-1 on CD8+ T cells may facilitate local immune evasion, leading to EBV persistence and ongoing inflammation in the MS brain (40). Here, CD8A is linked to myeloid sarcoma.